Fujifilm Joins MBC Biolabs as Sponsor to Foster Innovation in Biotech
MBC BioLabs is excited to announce a strategic partnership with Fujifilm Open Innovation Hub to support biotech collaboration and innovation in our startup ecosystem.
Mitokinin, Inc., Enters into Purchase Right Agreement with AbbVie
AbbVie, a leading global biopharmaceutical company, has purchased an exclusive right to acquire Mitokinin following completion of IND enabling studies on Mitokinin's lead PINK1 compound.
Cage Bio closes $7.2 million round of series A funding
The investment was led by professional and angel investor groups consisting of current and former pharmaceutical executives and physicians.
BigHat Biosciences Raises $19 Million in Series A Funding
BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, announced it has raised $19 million in an oversubscribed Series A funding round.
Charles River Announces Strategic Partnership with Cypre
The partnership will provide Charles River clients with access to Cypre’s proprietary 3D tumor model platform, Falcon-X™, which will expand Charles River’s 3D in vitro testing services to further optimize immuno-oncological approaches for its clients.
Biotech David Faces a Goliath
MBC BioLabs alum, Trevor Martin, is named Executive of the Year 2020 by San Francisco Business Times